Introduction
Leadless Pacemakers (Micra, Medtronic, Minneapolis, USA) are implanted because of occluded subclavian or superior cava veins, or to reduce the risk of lead associated complications like lead injury, dislocation, infection etc. Leadless Pacemaker implantation rates are increasing worldwide. At the end of 2017, more than 10'000 patients in 40 countries had such an implanted device. 1 In a recently published registry with 795 patients, successful device implantation was possible in 99.6% of cases, and major complications occurred only in 1.51% of cases. 2 Until now, leadless pacemaker extraction has rarely been reported, 3 pulmonary vein in a patient with a congenital heart defect. 4 We report here on a patient with an acute leadless pacemaker device dislocation after one day with subsequent successful percutaneous device extraction.
Timeline

Case presentation
An 83-yearold patient was admitted to our hospital due to suspected amyloidosis. The patient presented with dyspnoea, ascites and suspicious left ventricular hypertrophy (ventricular septum thickness 25 mm). In the physical examination findings on admission, he showed slight leg oedema. Besides of that, no signs of cardiac congestion were present. He had systolic murmur at the 4th intercostal area. Otherwise, physical examination was normal.
The patient had a moderately impaired left ventricular function, chronic atrial fibrillation, a known left bundle brunch block, a higher degree tricuspid insufficiency, and a moderate mitral insufficiency.
We conducted cardiac magnetic resonance imaging, and the findings were in accordance with the suspected amyloidosis. In the laboratory results, we could not detect light chains or results in accordance with multiple myeloma or MGUS. Obstructive coronary artery disease and pulmonary hypertension were ruled out by invasive coronary angiography and right heart catheterization. In the following night, the patient developed higher degree heart block with a need for temporary pacing. Three days later, the decision for a permanent pacemaker was made due to ongoing complete heart block. Owing to the presence of a moderate to severe tricuspid regurgitation, the placement of a leadless pacemaker was scheduled.
The implantation of the leadless pacer device was performed using fluoroscopy and echocardiography guidance, and the procedure was done according to the manufacturer's training recommendation. The procedure was aggravated due to a very thick moderator band that led to a difficult placement. Nevertheless, the leadless pacer device could be successfully implanted into the septum close to the moderator band, showing good sensing and pacing values. Additionally, in the tilt test, at least three tines were firmly secured.
After catheter and sheath removal, the patient developed a short phase (about 1 second) with loss of capture of the pacer device.
However, a second periprocedural interrogation showed stable pacing and sensing values. Therefore, the temporary pacing lead was maintained on a backup pacing mode. The next morning, the leadless pacemaker showed an exit block with device dislocation just below the tricuspid valve on echocardiography and device extraction was scheduled for the next day. Because the leadless pacemaker could not be visualized below the tricuspid valve after the first movement, and we feared that it dislocated into the pulmonary artery, a cardiac CT study was performed; with the result that the device was located at the right ventricular apex (Figure 1) . However, during the next night, it moved back to the postero-septal right ventricular groove below the tricuspid valve. With each device movement, which occurred at least three times, the patient developed a non-sustained ventricular tachycardia. Device extraction was not scheduled on the same day, because we felt that a specialist for tricuspid clipping should be present during the procedure.
For device extraction, external pacing patches were applied and the leadless pacemaker sheath (Micra introducer, Medtronic, Minneapolis, USA) was inserted via the right femoral vein (for the position of the dislocated leadless pacemaker, see Figure 2 ). Into this sheath, the following additional items were inserted: first, a 14 french short sheath for hemostasis; second, a large curve steerable introducer (Agilis, Abbott, Abbott Park, Illinois, USA); third, a 6 F Amplatz (AL 2, Cordis, Milpitas, USA) diagnostic catheter with a snare (Amplatz Goose Neck 20 mm). After multiple repositionings, it was possible to snare one of the 'FlexFix' tines. However, it was not possible to retrieve the device out of the tricuspid valve. Therefore, a second large curve steerable introducer (Agilis, Abbott, Abbott Park, Illinois, USA) was inserted into the left femoral vein. Via the 2 nd introducer, another Amplatz diagnostic catheter (AL 2, Cordis, Milpitas, USA) and another snare (Amplatz Goose Neck 20 mm) were introduced. Again, after multiple repositionings, it was possible to snare the body of the leadless pacemaker capsule. With both the snared tine and the body of the capsule, the device was finally retrieved successfully into the leadless pacemaker delivery sheath (Micra introducer, Medtronic, Minneapolis, USA) and extracted (see Figures 3 and  4) . The entire procedure lasted 189 minutes. No pericardial effusion or aggravation of the tricuspid regurgitation occurred. Afterwards, the patient was implanted with a conventional VVI pacemaker and was successfully discharged. Unfortunately the patient did not come for a follow-up visit.
Discussion
Implantable transcatheter leadless pacemakers can be implanted safely most of the time. However, in rare cases device dislocations may occur. Until now, only one case of device dislocation has been published, 4 in which a patient with congenital heart disease was treated with a leadless pacemaker which dislocated into the pulmonary artery, and could be safely extracted. In two other cases, device extraction had to be performed due to loss of capture several weeks after implantation or device infection. 3, 5 In theory, a dysfunctional leadless pacemaker can be removed by retrieving the device via the proximal retrieval feature into a leadless pacemaker delivery sheath after implanting a new device with the aim of reducing the risk of perforation or damage to the tricuspid valve, because the 'FlexFix' tines are pulled back into the proximal retrieval feature inside the right ventricle. However, since the reason for the dislocation of the current device was unknown in this case, we opted for implanting a conventional pacemaker. In addition, an 'empty' proximal retrieval feature is not available. It should also be mentioned that during our attempts to retrieve the dislocated leadless pacemaker, we were unable to snare the proximal retrieval feature. This was also the case in the other three reported cases. [3] [4] [5] We assume that our inability to snare the proximal retrieval feature was mainly due toanatomical reasons; in particular, the device was located too close to the septum. The most feared complication in our case was further damage to the tricuspid valve and pericardial tamponade because of the 'FlexFix' tines. Fortunately, this did not happen.
Until now, no data on leadless pacemaker implantation in patients with cardiac amyloidosis have been published. It can be hypothesized that in such cases, the device tines may slip due to the presence of amyloid between the myocytes. Another explanation is that the large moderator band led to an incomplete fixation of the 'FlexFix' tines.
Conclusion
In very rare cases, leadless pacemaker dislocation can occur. Device extraction is possible, but is described as challenging in most published cases. One snare is holding a fixation tine (right side) and the other snare is holding the Micra body. In addition, temporary pacing lead. RA, right atrium; RV, right ventricle; TV, tricuspid valve.
